Summary Invasive potentials of malignant cancer cells are regulated by cell motility factors. To examine the regulation of motility and invasiveness in oral squamous carcinoma, we investigated autocrine-and/or paracrine-acting cell motility factors, using a newly established human cell line (IF cells) from oral squamous cell carcinoma, which has highly invasive and metastatic characteristics. Conditioned medium derived from IF cells stimulated cell scattering and migration of GB-d1 gallbladder carcinoma cells, indicating that IF cells secreted cell motility factors. Using antibodies, IF-derived cell motility factors proved to be transforming growth factor (TGF)-α and TGF-β1. Antibodies against TGF-α and TGF-β1 inhibited autonomous migration of the IF cells. On the other hand, in vitro invasion of IF cells was strongly enhanced by hepatocyte growth factor (HGF) but only slightly by TGF-α and TGF-β1. The conditioned medium from fibroblasts enhanced in vitro invasion of IF cells, an event abrogated by anti-HGF antibody, but not by antibodies against TGF-α and TGF-β1. Importantly, IF cells secreted a factor inducing HGF production in fibroblasts and the factor was identified as interleukin-1, which means that a mutual interaction exists between tumour cells and fibroblasts, as mediated by the HGF/HGF-inducer loop. These results indicate that IF cells utilize TGF-α and TGF-β1 as autocrine-acting motility factors and HGF as a paracrine-acting motility factor, and that invasiveness of IF cells is particularly stimulated by HGF derived from stromal fibroblasts. Utilization of multiple cell motility/invasion factors that act in distinct pathways may confer highly invasive and metastatic potentials in IF oral squamous carcinoma cells.
The transition from in situ tumour growth to invasive and metastatic disease is initially characterized by the potential of the tumour cells at the primary site to cross tissue barriers and to invade local tissues. In case of malignant tumours originating from epithelial tissue, cells in the primary tumour lose adherent cell-cell interaction, create a pathway through basement membrane and surrounding stroma, and migrate through the pathway it has created. Thus, degradation of local extracellular matrix components and accompanying cellular movement are particular characteristics associated with invasive tumours.
Studies done in the past decade revealed a unique group of cell motility factors and that many growth factors and ligands for receptor tyrosine kinases share motogenic activity (enhancement of cell motility) (reviewed in Stoker and Gherardi, 1991; Wright et al, 1993; Levine et al, 1995; Chicoine and Silbergeld, 1997) . Scatter factor was originally identified as fibroblast-derived motility factor for epithelial cells (Stoker and Perryman, 1985) , while subsequent purification and characterization revealed this factor to be identical to hepatocyte growth factor (HGF) (Gherardi et al, 1989; Weidner et al, 1990 Weidner et al, , 1991 Furlong et al, 1991; Konishi et al, 1991; Naldini et al, 1991) . HGF was originally identified and cloned as a mitogenic polypeptide for hepatocytes (Nakamura et al, 1984 Russell et al, 1984; Miyazawa et al, 1989) .
Several growth factors, initially identified as mitogenic polypeptides, also affect motility of a wide variety of cells, including platelet-derived growth factor (PDGF), insulin-like growth factor-I (IGF-I), IGF-II, basic fibroblast growth factor (bFGF), transforming growth factor (TGF)-α and TGF-β1 (also see above reviews). These cell motility factors play important roles in regulating cell movement in physiological and pathological processes, including embryogenesis, tissue repair, inflammation as well as tumour invasion (reviewed in Levine et al, 1995; Chicoine and Silbergeld, 1997; Wehrle-Haller and Weston, 1997; Birchmeier and Gherardi, 1998) .
Migration and invasion of cancer cells are particularly regulated by cell motility factors which act in autocrine-and/or paracrinerelated manner. Establishment of an autocrine loop of growth factors is involved in tumorigenic transformation and progression to malignant cancer cells (Sporn and Roberts, 1985; Ullrich and Schlessinger, 1990; Wright et al, 1993; Levine et al, 1995; Silletti and Raz, 1996; Chicoine and Silbergeld, 1997) . In addition to these factors, participation of paracrine factors have been implicated in tumour invasion and malignant progression, as based on the notion that growth and invasive potentials of carcinoma cells are influenced through interactions with host stromal cells (van den Hooff, 1988; Matsumoto et al, 1989; Camps et al, 1990; Wernert, 1997) . HGF is a mesenchymal-(or stromal-)derived paracrine factor which affects cell growth, cell motility and morphogenesis of a wide variety of cells, including malignant ones (Jiang et al, 1993; Matsumoto and Nakamura, 1997; Birchmeier and Gherardi, 1998) . In vitro, HGF stimulates migration or Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line invasion of various types of carcinoma cells (Weidner et al, 1990; Matsumoto et al, 1994; Shibamoto et al, 1994; Jeffers et al, 1996; Bennett et al, 1997; Inoue et al, 1997; Nakamura et al, 1997 ; also reviewed in Jiang et al, 1998) and autonomous activation of cMet/HGF receptor through the autocrine loop of HGF confers invasive and metastatic potential of tumour cells (Jeffers et al, 1996) .
Oral squamous cell carcinomas are generally malignant tumours, with invasive and metastatic potentials. We established a distinct tumour cell line (IF cells) from a patient with oral squamous cell carcinoma. These IF cells are highly invasive and metastatic when implanted into athymic mice and thus IF cells retain invasive and metastatic potential (manuscript in preparation). We hypothesized that cell motility and invasiveness of IF cells might be regulated by cell motility factors which act in an autocrine or paracrine manner. In the present study, we identified paracrine and autocrine cell motility factors in this tumour cell line. Therefore, IF oral squamous cell carcinoma cells utilize both autocrine-and paracrineacting cell motility factors and utilization of these multiple factors presumably confers invasive and metastatic potential in this malignant oral squamous carcinoma cell line.
MATERIALS AND METHODS

Materials
Mouse monoclonal antibodies against human TGF-α and TGF-β1 were obtained from Calbiochem, Calbiochem-Novabiochem Int. (Cambridge, MA, USA) and TAGO Products (Burlingame, CA, USA) respectively. Polyclonal antibody against HGF was prepared from the serum of a rabbit immunized with human recombinant HGF and 1 µg ml -1 anti-human HGF IgG completely neutralized the biological activities of 1 ng ml -1 of human HGF (Matsumoto et al, 1996) . Human recombinant TGF-α was kindly provided by Genentec (San Francisco, CA, USA) and TGF-β1 was purified from human platelets (Okada et al, 1989) . HGF was purified from the culture media of Chinese hamster ovary cells transfected with an expression plasmid containing human HGF cDNA . Human recombinant interleukin-1 receptor antagonist (IL-1 RA) was obtained from R & D Systems Inc. (Minneapolis, MN, USA). Antibody against human PDGF was obtained from Promega (Madison, WI, USA).
Cell culture
IF cells were originally established from a patient with squamous cell carcinoma of gingiva of the lower jaw. The cells were cultured in α-modified Eagle's medium (α-MEM) supplemented with 10% fetal bovine serum (FBS). MDCK clone 3B (Madin-Darby Canine Kidney) epithelial cells and GB-d1 human gallbladder carcinoma cells were kind gifts from Dr R Montesano (University of Geneva) and Dr H Shimura (Fukuoka University) respectively. MDCK and GB-d1 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS. Human dermal and oral fibroblasts were initially allowed to proliferate outward from tissue obtained during surgery and the cells were cultured in DMEM supplemented with 10% FBS.
Assay for cell growth and scattering
IF cells were plated at 500 cells cm -2 in 12-well plates in α-MEM supplemented with 10% FBS and cultured for 24 h. The culture media was replaced by α-MEM containing 1% FBS and the cells were cultured in the absence or presence of 10 ng ml -1 HGF, TGF-α or TGF-β1 for 72 h. The number of cells was counted using a Coulter counter after dissociation by trypsin.
For cell scattering assay, MDCK or GB-d1 cells were plated at 2.5 × 10 3 cells cm -2 in DMEM containing 10% FBS and cultured for 24 h. The conditioned medium from IF cells or growth factors were added, cells were further cultured for 24 h, placed under a microscope and photographed.
Measurement of HGF production
Human skin or oral fibroblasts were seeded on 48-well plates at a density of 5 × 10 4 cells cm -2 and cultured for 24 h. After replacing the media with fresh DMEM supplemented with 1% FBS and 2 µg ml -1 heparin, appropriate amounts of cytokines or the conditioned medium from IF cells was added and the cells were cultured for 24 h. The concentration of HGF in culture media was measured by enzyme-linked immunoabsorbent assay (ELISA), using a kit (Institute of Immunology Co. Ltd, Tokyo, Japan).
In vitro migration assay
Migration of tumour cells was carried out using Transwell chamber equipped with a filter membrane with 8-µm pores (Corning Costar Co., Cambridge, MA, USA). Tumour cells were plated at 5 × 10 4 cells cm -2 in the upper compartment of the chamber, and cultured for 24 h, fixed in 70% ethanol and stained with haematoxylin and eosin. The number of cells migrating to the undersurface of the membrane through the pores was counted, as viewed microscopically. Six microscopic fields were randomly selected for cell counting. To examine the inhibitory effects of specific antibodies on migration of tumour cells, antibodies against TGF-α, TGF-β and HGF were added at 10 µg ml -1 .
In vitro invasion assay
In vitro invasion of tumour cells was measured using the Biocoat Matrigel Invasion Chamber (Becton Dickinson Labware, Bedford, MA, USA). In this apparatus, Matrigel basement membrane components are reconstituted on a filter membrane with 8-µm pores. The cells were plated at a density of 10 5 cells cm -2 on the Matrigel in the upper compartment of the chamber and cultured for 48 h. The number of cells that invaded the undersurface of the membrane was counted, as described above. To examine the extent of invasion of IF cells into collagen gel matrix, the tumour cells were embedded in collagen gel (Type I Collagen, Nitta gelatin, Osaka, Japan) at 5 × 10 3 cells ml -1 , and cultured for 7 days. The culture medium was changed every second day.
RESULTS
Production and identification of motility factors from IF cells
IF cells were established from a lymph node metastasis of poorly differentiated squamous cell carcinoma which had primarily developed in the lower jaw. Histologically the tumour was highly infiltrative and invaded the capsular sheath of metastasized lymph nodes. When IF cell were subcutaneously implanted in the To identify motility factor(s) derived from IF cells, we asked if known growth factors and cytokines would induce scattering of GBd1 cells (Figure 1 ). Among various growth factors and cytokines tested, TGF-α, TGF-β1 and HGF showed scattering effects on GBd1 cells (Figure 1 E-G), while PDGF, bFGF, vascular endothelial cell growth factor, IL-1β, IL-2, IL-6 and tumour necrosis factor-α did not induce cell scattering (not shown). We therefore examined effects of antibodies against TGF-α, TGF-β1 and HGF on cell scattering activity in IF-derived conditioned medium. When an antibody against TGF-α or TGF-β1 was added to the conditioned medium of IF cells, cell scattering activity in the medium was significantly inhibited (Figure 1 H, I ), whereas anti-HGF antibody had no inhibitory effect on the cell scattering induced by IF-derived medium (Figure 1, J) . This finding meant that IF-derived cell motility factors might be TGF-α and TGF-β1.
For further evidence that IF-derived motility factors are TGF-α and TGF-β1, migration of GB-d1 cells was quantitatively analysed using a Transwell apparatus (Figure 2 ). GB-d1 gallbladder carcinoma cells were seeded on Transwell filter membrane and the number of cells migrating to the undersurface of the membrane through 8-µm pores was counted. When IF-derived conditioned medium was added, the number of migrated cells greatly increased. However, the addition of anti-TGF-α and anti-TGF-β1 antibodies inhibited migration of GB-d1 cells: the inhibitory effect of anti-TGF-β1 antibody was more potent than that of anti-TGF-α ( Figure 2E ). These results indicate that IF cells do secrete cell motility factors, which proved to be TGF-α and TGF-β1.
Autocrine regulation of IF cell motility by TGF-β1 and TGF-α
Based on the finding that IF cells secreted TGF-α and TGF-β1 as cell motility factors, we analysed the regulation of IF cell motility by TGF-α, TGF-β1 and HGF, using Transwell assay. When TGF-α, TGF-β1 and HGF were individually added to culture of IF cells the migration of IF cells was dose-dependently stimulated by these growth factors ( Figure 3A) . Although a significant number of IF cells migrated through the membrane in control culture, migration of IF cells was further stimulated by these growth factors, in a dose-dependent manner. The potential to stimulate migration of IF cells was HGF > TGF-α > TGF-β1. HGF was most potent in stimulating IF cell motility and fivefold enhancement was seen with 10 ng ml -1 HGF. We also examined effects of these growth factors on proliferation of IF cells ( Figure 3B ). When the cells were cultured in the absence or presence of growth factors for 72 h, both TGF-α and HGF weakly stimulated the proliferation of IF cells, whereas TGF-β1 inhibited IF cell proliferation; therefore HGF and TGF-α are weak mitogens while TGF-β1 inhibits growth of IF cells.
To observe if the motility of IF cells was regulated by these factors in an autocrine manner, effects of antibodies on autonomous migration of IF cells were tested, using Transwell assay (Figure 4) . When antibodies against TGF-α and TGF-β1 were added, migration of IF cells was inhibited to 49% and 33% of the control culture respectively. Simultaneous addition of these antibodies inhibited migration of IF cells to lower levels than seen in cases of anti-TGF-β1 or anti-TGF-α antibody alone. However, anti-HGF antibody had no significant effect on the autonomous migration of IF cells. Consistent with this, HGF was not detected in conditioned medium of IF cells by ELISA (not shown). Therefore, although TGF-α, TGF-β1 and HGF stimulate migration of IF cells, TGF-α and TGF-β, but not HGF, act as autocrine cell motility factors which regulate their own cell motility.
Induction of fibroblast production of HGF by IF-derived factor
Although IF cells do not produce HGF and HGF does not act as an autocrine motility factor in IF cells, we speculated that stromal fibroblasts-derived HGF might affect migration of IF cells in a paracrine manner. We previously showed that several types of 
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Figure 5 Enhancement of HGF production in human skin fibroblasts by IF-derived conditioned medium (A) and its inhibition by IL-1 receptor antagonist (B). Human skin fibroblasts were cultured in the absence or presence of IF-derived conditioned medium or 1 ng ml -1 IL-1β and HGF production during 24-h culture of the fibroblasts was measured (A). IF-derived conditioned medium was added at 10% (v/v) to cultures of fibroblasts and various concentrations of IL-1 receptor antagonist (IL-1RA) were added (B) carcinoma cells secrete inducing factors for HGF production in normal human fibroblasts (Matsumoto et al, 1996; Nakamura et al, 1997) . We therefore examined if IF cells would produce an inducing factor for HGF production in normal human fibroblasts derived from dermal tissue. When IF-derived conditioned medium was added to culture of human fibroblasts, HGF production by fibroblasts was dose-dependently stimulated and the maximal stimulatory effect by 4.4-fold was comparable to that seen with 1 ng ml -1 IL-1β ( Figure 5A ). Therefore, IF cells secrete a potent inducing factor for HGF production in fibroblasts.
To identify the IF-derived inducing factor for HGF production, we tested effects of antibodies and antagonistic molecules for inducers of HGF production in fibroblasts, including anti-bFGF, anti-PDGF and an IL-1 receptor antagonist. Addition of an IL-1 receptor antagonist suppressed the inducing activity in IF-derived conditioned medium to close to basal level ( Figure 5B ), whereas anti-bFGF and anti-PDGF antibodies had no significant effect on HGF-inducing activity in IF-derived conditioned medium (not shown). This finding indicates that IF cells secrete IL-1 (IL-1α, IL-1β1 or both) as an HGF inducer for stromal fibroblast. Similar results were obtained when fibroblasts derived from oral stromal tissue were used, while IL-1β was less potent in stimulating HGF production than that seen with skin fibroblasts (not shown).
Regulation of IF tumour invasiveness
Our findings indicate that motility of IF cells is regulated by at least three distinct growth factors: TGF-α and TGF-β1 act as autocrine motility factors, while HGF may act as a paracrine motility factor derived from stromal fibroblasts. We then asked whether the invasiveness of IF cells is regulated by these autocrine and paracrine motility factors. IF tumour cells were seeded on Matrigel invasion chamber and cultured for 48 h in the absence or presence of TGF-α, TGF-β1 or HGF (Figure 6 ). In this apparatus, invasive cells degrade Matrigel extracellular matrix components and then migrate to the undersurface of the membrane. During 48-h culture, a few cells invaded through Matrigel components and a filter membrane in the absence of growth factors. When IF cells were cultured in the presence of HGF, the number of invaded cells greatly increased: fourfold enhancement by HGF. However, both TGF-α and TGF-β1 weakly stimulated invasion of IF cells and their potency in stimulating invasion of IF cells was much less than that of HGF. On the other hand, addition of conditioned medium from human oral stromal fibroblasts also stimulated the invasion of IF cells. The stimulatory effect by this medium was little inhibited by antibodies against TGF-α and TGF-β1 but was greatly suppressed by anti-HGF antibody.
We next analysed invasiveness of IF tumour cells cultured in collagen gel matrix (Figure 7) . When IF cells were grown in collagen gel matrix for 6 days in the absence of growth factors, they grew in a cystic structure with no invasive characteristics ( Figure 7A, G) . In contrast, when the cells were grown in the presence of HGF, they showed invasive and some characteristics of scattering ( Figure 7D ). Transverse section of these cells showed that IF cells lost cell-cell contact and several cells invaded the collagen gel matrix ( Figure 7H) . Similarly, the addition of conditioned medium from human oral stromal fibroblasts to cultures of IF cells induced significant invasive characteristics ( Figure 7E ). In contrast, addition of TGF-α or TGF-β1 did not induce invasive characteristics in IF cells grown in collagen gels ( Figure 7B, C) . Importantly, the invasive phenotype induced by fibroblast-derived conditioned medium was almost completely prevented by anti-HGF antibody ( Figure 7F ), but not by anti-TGF-α and anti-TGF-β1 antibodies (not shown). These observations mean that the invasiveness of IF cells is potently stimulated by HGF, but only marginally so by TGF-α and TGF-β1.
DISCUSSION
Malignant tumours are characterized by unrestrained growth and invasion into surrounding host tissue. Tumour invasion involves the active locomotion of tumour cells into and through host tissue barriers. Various polypeptide growth factors such as epidermal growth factor, PDGF, TGF-α, TGF-β1 and HGF stimulate not only cell proliferation but also chemotactic migration of various types of tumour cells. Likewise, a few classes of proteins which predominantly stimulate the motility of cells have been identified, using assay systems that measure cell motility (Stoker and Gherardi, 1991; Levine et al, 1995; Silletti and Raz, 1996) . It is reasonable to consider that these motility factors are responsible for the highly motile behaviour in invasive tumour cells. Using human oral squamous carcinoma cell line, we analysed the regulation of cellular motility and invasiveness by extracellularly acting proteins produced by tumour cells themselves and stromal + CM from fibroblasts , CM from human oral stromal fibroblasts at 50% (v/v) and antibodies (α-TGF-α, α-TGF-β1, α-HGF) were at 10 µg ml -1 fibroblasts. We identified TGF-α and TGF-β1 to be autocrineacting motility factors, and HGF to be a stromal-derived paracrine motility factor in IF oral squamous carcinoma cells (Figure 8) . Importantly, the invasiveness of IF cells was potently stimulated by HGF, but not by TGF-α and TGF-β1.
TGF-α and TGF-β1 were originally identified as tumourderived factors which confer anchorage-independent tumour growth, while subsequent studies showed that TGF-α and TGF-β1 are produced in a wide variety of tumour cells and regulate their own growth and motility (Derynck et al, 1987; Sporn et al, 1987; Wright et al, 1993; Wright and Huang, 1996) . Several investigators noted that TGF-β1 stimulates migration and invasion of distinct types of tumour cells, through an autocrine or a paracrine manner (Welch et al, 1990; Mooradian et al, 1992; Wright et al, 1993 ; Wright and Huang, 1996; Chicoine and Silbergeld, 1997; Inoue et al, 1997) . Likewise, TGF-α stimulates migration and invasion of certain types of tumour cells such as endometrial adenocarcinoma, glioma and uterine cervical carcinoma cells (Ueda et al, 1996 (Ueda et al, , 1997 El Obeid et al, 1997) . We identified motility factors derived from IF oral squamous cell carcinoma cells as TGF-α and TGF-β1. Since autonomous migration of IF cells was significantly inhibited by antibodies against TGF-α and TGF-β1, these growth factors may play a role as autocrine-acting cell motility factors which stimulate self migration in IF oral carcinoma cells. On the other hand, HGF stimulates the motility of a diversity of cells, including normal epithelial cells, endothelial cells and a wide variety of tumour cells (reviewed in Jiang et al, 1993 Jiang et al, , 1998 Zarnegar and Michalopoulas, 1995; Matsumoto et al, 1997) . It is noteworthy that, although the motility of IF cells is enhanced by TGF-α, TGF-β1 and HGF, invasion of IF cells is particularly regulated by HGF rather than by TGF-α and TGF-β1. Similarly, we previously noted that the invasiveness of GB-d1 gallbladder cancer cells is potently stimulated by HGF but not TGF-α and TGF-β1, while TGF-α and TGF-β1 both stimulate migration of the cells (Matsumoto et al, 1996) . Therefore, cellular responsiveness to stimulatory effects of TGF-α and TGF-β1 on invasion of cancer cells seems to be cell type-dependent. Nevertheless, we speculate that the production of TGF-α and TGF-β1 and autocrine activation of their receptors may be involved in invasive and metastatic behaviour in IF cells. Coexistence of TGF-α and TGF-β1 supports anchorage-independent growth in cancer cells (Derynck et al, 1987; Sporn et al, 1987) , which is likely to increase metastatic potential. Enhancement of tumour migration by TGF-α and TGF-β1 may possibly increase invasiveness in IF cells, in collaboration with stromal-derived HGF.
Invasiveness of tumour cells involves disruption of cell-cell adhesion, enhanced cycle of detachment and attachment of cell-substrate interaction, breakdown of extracellular matrix components and enhanced cell motility. HGF induces tyrosine phosphorylation of β-catenin (Watabe et al, 1993; Shibamoto et al, 1994; Hiscox and Jiang, 1999) and focal adhesion kinase (Matsumoto et al, 1994) . HGF activates Rho small GTP-binding protein (Takaishi et al, 1994; Ridly et al, 1995) , by which intracellular cytoskeletal rearrangement occurs. These events are likely to lead to increased cell motility, dissociation of cell-cell interaction and remodelling of cell-substrate interactions. In addition to these events, HGF induces urokinase-type plasminogen activator (uPA) expression (Pepper et al, 1992; Jeffers et al, 1996; Bennett et al, 1997; Date et al, 1998) and stimulates the production of matrix metalloproteinases (MMPs) (Dunsmore et al, 1996; Bennett et al, 1997; Date et al, 1998) . Jeffers et al (1996) demonstrated that induction of the uPA proteolysis network by HGF is coupled to enhanced tumorigenicity and invasive and metastatic properties in certain tumour cell lines. Since the induction and/or activation of proteinases that break down extracellular matrix components seem to be, at the least, critical for induction of invasive potential also in IF tumour cells, we analysed changes in activities of uPA and gelatinases (MMP-2 and MMP-9) in IF cells treated with TGF-α, TGF-β1 or HGF. However, we could not find specific changes in these proteinase activities that correlate to distinct potentials of TGF-α, TGF-β1 and HGF to stimulate invasiveness of IF tumour cells. Identification of extracellular matrix proteinases responsible for the induction of invasiveness by HGF remains to be addressed. Nevertheless, cooperative activation of multiple events driven by cMet/HGF receptor activation seems to be a cause for particular potency of HGF to stimulate the invasion of IF oral carcinoma cells, as well as other tumour cells.
Several lines of studies indicate that the growth and invasive potential of carcinoma cells are influenced through interaction with host stromal cells (van den Hooff, 1988; Matsumoto et al, 1989; Camps et al, 1990; Wernert, 1997) . Indeed, the in vitro invasion of various human oral squamous carcinoma cells into collagen gel matrix was specifically induced by co-cultivation with stromal fibroblasts (Matsumoto et al, 1989 ) and the fibroblast-derived factor responsible for invasion of oral carcinoma cells proved to be HGF (Matsumoto et al, 1994) . Thus these earlier findings apparently coincide with our present results: invasion of IF oral squamous carcinoma cells is particularly stimulated by stroma-derived HGF. Moreover, of interest in this study is that IF cells secrete IL-1 as a potent inducer for production of HGF in stromal fibroblasts. We reported that several types of carcinoma cells secrete inducers for HGF production in fibroblasts and fibroblast-derived HGF stimulates invasion of carcinoma cells. IL-1, bFGF and PDGF were identified as tumour-derived HGFinducers (Matsumoto et al, 1996; Nakamura et al, 1997) . There may be mutual paracrine interactions between IF tumour cells and fibroblasts: IL-1 derived from IF tumour cells activates neighbouring fibroblasts to up-regulate HGF production, while fibroblast-derived HGF in turn affects invasion of IF cells (Figure 8) . Moreover, HGF has angiogenic activity (Bussolino et al, 1992; Grant et al, 1993) and breast carcinoma cells capable of producing HGF induced more extensive angiogenesis in vivo than that seen in parental cells incapable of producing HGF (Lamszus et al, 1997) . Taken together, HGF seems to increase invasive and angiogenic characteristics in IF tumours through a paracrine interaction.
We used a newly established IF human oral squamous carcinoma cell line which possesses highly invasive and metastatic potentials, and identified distinct cells that affect motility and invasiveness of tumour cells in an autocrine or paracrine fashion. The utilization of multiple cell motility/invasion factors that act in distinct pathways in IF oral squamous carcinoma cells may confer highly invasive and metastatic potentials in microenvironments of tumour. Finally, based on the finding that local interaction between IF cells and fibroblasts, as mediated by HGF, is a mechanism leading to even more invasive events, we propose that disruption of this mutual interaction may be one strategy for prevention of tumour invasion and metastasis. In this context, the application of a newly identified four kringle containing antagonist for HGF (Date et al, 1997 (Date et al, , 1998 can be tested for potential therapeutic value in suppressing invasion and metastasis of malignant oral squamous carcinoma cells. 
